129 related articles for article (PubMed ID: 31320522)
1. Making precision medicine personal for cystic fibrosis.
Manfredi C; Tindall JM; Hong JS; Sorscher EJ
Science; 2019 Jul; 365(6450):220-221. PubMed ID: 31320522
[No Abstract] [Full Text] [Related]
2. Towards personalized medicine for cystic fibrosis patients with rare mutations.
Csanády L
J Physiol; 2024 Jan; 602(2):257-258. PubMed ID: 38167788
[No Abstract] [Full Text] [Related]
3. Treatment of Fetal Cystic Fibrosis With Cystic Fibrosis Transmembrane Conductance Regulator Modulation Therapy.
Blumenfeld YJ; Hintz SR; Aziz N; Barth RA; Spano JM; El-Sayed YY; Milla C
Ann Intern Med; 2023 Jul; 176(7):1015-1016. PubMed ID: 37307583
[No Abstract] [Full Text] [Related]
4. A personalized medicine approach to optimize care for a pediatric cystic fibrosis patient with atypical clinical symptoms.
Lee J; Husami A; Arora K; Zhang W; Kadri F; Yarlagadda S; Moon C; Mun KS; Zhang K; Huang Y; Liyanage P; Brewington J; Clancy JP; Shaikhkhalil A; Paul G; Naren AP
Pediatr Pulmonol; 2024 Jan; 59(1):229-232. PubMed ID: 37818777
[No Abstract] [Full Text] [Related]
5. Personalised medicine for non-classic cystic fibrosis resulting from rare CFTR mutations.
McCravy MS; Quinney NL; Cholon DM; Boyles SE; Jensen TJ; Aleksandrov AA; Donaldson SH; Noone PG; Gentzsch M
Eur Respir J; 2020 Jul; 56(1):. PubMed ID: 32265312
[No Abstract] [Full Text] [Related]
6. Nasal epithelial cells as a gold-standard predictive model for personalized medicine in cystic fibrosis.
Pedemonte N
J Physiol; 2022 Mar; 600(6):1285-1286. PubMed ID: 35038767
[No Abstract] [Full Text] [Related]
7. What Is Cystic Fibrosis?
Endres TM; Konstan MW
JAMA; 2022 Jan; 327(2):191. PubMed ID: 35015036
[No Abstract] [Full Text] [Related]
8. Precision medicine in cystic fibrosis: predictive role of forskolin-induced swelling assay.
Furstova E; Drevinek P; Novotna S; Libik M; Benesova K; Borek-Dohalska L; Sakmarova K; Modrak M; Macek M; Dousova T
Eur Respir J; 2024 Apr; 63(4):. PubMed ID: 38485147
[No Abstract] [Full Text] [Related]
9. Cystic Fibrosis.
Grasemann H; Ratjen F
N Engl J Med; 2023 Nov; 389(18):1693-1707. PubMed ID: 37913507
[No Abstract] [Full Text] [Related]
10. Gene Therapy for Cystic Fibrosis: Lessons Learned and Paths Forward.
Choi SH; Engelhardt JF
Mol Ther; 2021 Feb; 29(2):428-430. PubMed ID: 33472034
[No Abstract] [Full Text] [Related]
11. How many billions is enough? Prioritizing profits over patients with cystic fibrosis.
McGarry ME; Gibb ER; Laguna TA; O'Sullivan BP; Sawicki GS; Zobell JT
Pediatr Pulmonol; 2023 May; 58(5):1595-1597. PubMed ID: 36722731
[No Abstract] [Full Text] [Related]
12. [A systemic gene therapy for the treatment of cystic fibrosis].
Boillot L; Costes F
Med Sci (Paris); 2024 May; 40(5):467-470. PubMed ID: 38819285
[TBL] [Abstract][Full Text] [Related]
13. Primary nasal epithelial cells from patients with cystic fibrosis hold promise for guiding precision medicine and expanding treatment.
Reeves SR
Eur Respir J; 2021 Dec; 58(6):. PubMed ID: 34857588
[No Abstract] [Full Text] [Related]
14. Claudio Castanos-leader in cystic fibrosis care in Argentina.
Kirby T
Lancet Respir Med; 2023 Oct; 11(10):871. PubMed ID: 37802080
[No Abstract] [Full Text] [Related]
15. End-of-life care in cystic fibrosis in the era of new therapies.
Dellon EP; Goggin J
Lancet Respir Med; 2023 Oct; 11(10):861-863. PubMed ID: 37699422
[No Abstract] [Full Text] [Related]
16. Delivering precision medicine in oncology today and in future-the promise and challenges of personalised cancer medicine: a position paper by the European Society for Medical Oncology (ESMO).
Ciardiello F; Arnold D; Casali PG; Cervantes A; Douillard JY; Eggermont A; Eniu A; McGregor K; Peters S; Piccart M; Popescu R; Van Cutsem E; Zielinski C; Stahel R
Ann Oncol; 2014 Sep; 25(9):1673-1678. PubMed ID: 24950979
[No Abstract] [Full Text] [Related]
17. Cystic Fibrosis.
Mulrennan S; Jones AM
Semin Respir Crit Care Med; 2023 Apr; 44(2):185. PubMed ID: 36693409
[No Abstract] [Full Text] [Related]
18. Gain-of-Function Polymorphisms in Human Inflammasomes: Implications for Cystic Fibrosis.
Jeansonne D; Jeyaseelan S
Am J Respir Cell Mol Biol; 2021 Aug; 65(2):126-127. PubMed ID: 34033526
[No Abstract] [Full Text] [Related]
19. The past 10 years of cystic fibrosis treatment: the road to cure.
Castaños C
Lancet Respir Med; 2023 Oct; 11(10):864-865. PubMed ID: 37798057
[No Abstract] [Full Text] [Related]
20. Challenges to the optimisation of cystic fibrosis exacerbation treatment outcomes.
Goss CH; VanDevanter DR
Eur Respir J; 2024 Jun; 63(6):. PubMed ID: 38843940
[No Abstract] [Full Text] [Related]
[Next] [New Search]
